Abstract
The aim was to study possible associations between smoking habits and self-reported clinical features in a large population-based cohort of patients with psoriatic arthritis (PsA). All subjects with PsA who had sought health care in the period 2003–2007 were identified using a regional health-care register. In 2009, all those identified who were 18 years of age or more (n = 2,003) were sent a questionnaire with questions on smoking, health-related quality of life [EuroQol five-dimension (EQ-5D)questionnaire], function [Health Assessment Questionnaire (HAQ)], pain, fatigue, and global health. We performed age- and sex-adjusted regression analysis to compare health status outcomes in never and ever smokers. Altogether, 1,185 subjects (59 %) returned the questionnaire. Mean age was 57 years (SD 13.5), and 58 % were women; 38 % were never smokers and 62 % were ever smokers. Mean age at disease onset was 38.2 years (SD 13.2) and 41.2 years (SD 13.6), respectively (p = 0.001). In age- and sex-adjusted data, ever smokers reported worse EQ-5D (p = 0.009); worse reports of global health (p = 0.01), pain (p = 0.01), and fatigue (p = 0.04); and a higher number of painful body regions (p = 0.04) compared to never smokers. In this population-based PsA cohort, patients who were ever smokers reported worse health status than never smokers. Besides being a possible result of a worse PsA in ever smokers, impaired health status could also be an effect of unstudied comorbidities. Further longitudinal studies are needed to gain a better understanding of cause and effect. However, smoking cessation should be recommended because of general health considerations as well as disease-specific issues.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Westhoff G, Rau R, Zink A (2008) Rheumatoid arthritis patients who smoke have a higher need for DMARDs and feel worse, but they do not have more joint damage than non-smokers of the same serological group. Rheumatology (Oxford) 47(6):849–854
Mattey DL, Dawson SR, Healey EL, Packham JC (2011) Relationship between smoking and patient-reported measures of disease outcome in ankylosing spondylitis. J Rheumatol 38(12):2608–2615
Braun J, Sieper J, Zink A (2012) The risks of smoking in patients with spondyloarthritides. Ann Rheum Dis 71(6):791–792
Li W, Han J, Qureshi AA (2012) Smoking and risk of incident psoriatic arthritis in US women. Ann Rheum Dis 71(6):804–808
Eder L, Shanmugarajah S, Thavaneswaran A, Chandran V, Rosen CF, Cook RJ, Gladman DD (2012) The association between smoking and the development of psoriatic arthritis among psoriasis patients. Ann Rheum Dis 71(2):219–224
Tillett W, Jadon D, Shaddick G, Cavill C, Korendowych E, de Vries CS, McHugh N (2013) Smoking and delay to diagnosis are associated with poorer functional outcome in psoriatic arthritis. Ann Rheum Dis
Setty AR, Curhan G, Choi HK (2007) Smoking and the risk of psoriasis in women: Nurses’ Health Study II. Am J Med 120(11):953–959
Li W, Han J, Choi HK, Qureshi AA (2012) Smoking and risk of incident psoriasis among women and men in the United States: a combined analysis. Am J Epidemiol 175(5):402–413
Jankovic S, Raznatovic M, Marinkovic J, Jankovic J, Maksimovic N (2009) Risk factors for psoriasis: a case-control study. J Dermatol 36(6):328–334
Jamnitski A, Symmons D, Peters MJ, Sattar N, McInnes I, Nurmohamed MT (2013) Cardiovascular comorbidities in patients with psoriatic arthritis: a systematic review. Ann Rheum Dis 72(2):211–216
Johnsson H, McInnes IB, Sattar N (2012) Cardiovascular and metabolic risks in psoriasis and psoriatic arthritis: pragmatic clinical management based on available evidence. Ann Rheum Dis 71(4):480–483
Palmer KT, Syddall H, Cooper C, Coggon D (2003) Smoking and musculoskeletal disorders: findings from a British national survey. Ann Rheum Dis 62(1):33–36
Haglund E, Bremander AB, Petersson IF, Strombeck B, Bergman S, Jacobsson LT, Turkiewicz A, Geborek P, Englund M (2011) Prevalence of spondyloarthritis and its subtypes in southern Sweden. Ann Rheum Dis 70(6):943–948
EuroQol--a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy (Amsterdam, Netherlands) 1990, 16(3):199–208
Fries JF, Spitz P, Kraines RG, Holman HR (1980) Measurement of patient outcome in arthritis. Arthritis Rheum 23(2):137–145
Bergman S, Herrstrom P, Hogstrom K, Petersson IF, Svensson B, Jacobsson LT (2001) Chronic musculoskeletal pain, prevalence rates, and sociodemographic associations in a Swedish population study. J Rheumatol 28(6):1369–1377
Umana IC, Daniele CA, McGehee DS (2013) Neuronal nicotinic receptors as analgesic targets: it’s a winding road. Biochem Pharmacol
Reddy Thavanati PK, Kanala KR, de Dios AE, Cantu Garza JM (2008) Age-related correlation between antioxidant enzymes and DNA damage with smoking and body mass index. J Gerontol 63(4):360–364
Vassalle C, Maffei S, Ndreu R, Mercuri A (2009) Age-related oxidative stress modulation by smoking habit and obesity. Clin Biochem 42(7–8):739–741
Arnson Y, Shoenfeld Y, Amital H (2010) Effects of tobacco smoke on immunity, inflammation and autoimmunity. J Autoimmun 34(3):J258–J265
Acknowledgments
This study was supported by Region Skåne, by Lund University, and by grants from the Swedish Rheumatism Association.
Conflict of interest
The authors have no disclosures to declare.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bremander, A., Jacobsson, L.T.H., Bergman, S. et al. Smoking is associated with a worse self-reported health status in patients with psoriatic arthritis: data from a Swedish population-based cohort. Clin Rheumatol 34, 579–583 (2015). https://doi.org/10.1007/s10067-014-2742-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-014-2742-8